Shandong Weigao Group Medical Polymer Company Limited (FRA:UK2)
Germany flag Germany · Delayed Price · Currency is EUR
0.6200
-0.0100 (-1.59%)
At close: Apr 25, 2025, 10:00 PM CET

FRA:UK2 Statistics

Total Valuation

FRA:UK2 has a market cap or net worth of EUR 2.91 billion. The enterprise value is 2.60 billion.

Market Cap 2.91B
Enterprise Value 2.60B

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date Aug 28, 2025
Ex-Dividend Date Jun 2, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +0.66%
Shares Change (QoQ) -0.98%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 2.42B

Valuation Ratios

The trailing PE ratio is 10.64.

PE Ratio 10.64
Forward PE n/a
PS Ratio 1.68
PB Ratio 0.87
P/TBV Ratio 1.18
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 9.52
EV / Sales 1.65
EV / EBITDA 6.71
EV / EBIT 9.19
EV / FCF n/a

Financial Position

The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.17.

Current Ratio 3.20
Quick Ratio 2.55
Debt / Equity 0.17
Debt / EBITDA 1.33
Debt / FCF n/a
Interest Coverage 9.11

Financial Efficiency

Return on equity (ROE) is 8.77% and return on invested capital (ROIC) is 4.92%.

Return on Equity (ROE) 8.77%
Return on Assets (ROA) 4.15%
Return on Invested Capital (ROIC) 4.92%
Return on Capital Employed (ROCE) 7.92%
Revenue Per Employee 136,161
Profits Per Employee 21,502
Employee Count 12,719
Asset Turnover 0.38
Inventory Turnover 2.61

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +8.77% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +8.77%
50-Day Moving Average 0.62
200-Day Moving Average 0.55
Relative Strength Index (RSI) 48.82
Average Volume (20 Days) 398

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:UK2 had revenue of EUR 1.73 billion and earned 273.49 million in profits. Earnings per share was 0.06.

Revenue 1.73B
Gross Profit 864.87M
Operating Income 300.77M
Pretax Income 337.94M
Net Income 273.49M
EBITDA 415.81M
EBIT 300.77M
Earnings Per Share (EPS) 0.06
Full Income Statement

Balance Sheet

The company has 1.10 billion in cash and 554.88 million in debt, giving a net cash position of 546.35 million.

Cash & Cash Equivalents 1.10B
Total Debt 554.88M
Net Cash 546.35M
Net Cash Per Share n/a
Equity (Book Value) 3.35B
Book Value Per Share 0.69
Working Capital 1.77B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 49.94%, with operating and profit margins of 17.37% and 15.79%.

Gross Margin 49.94%
Operating Margin 17.37%
Pretax Margin 19.51%
Profit Margin 15.79%
EBITDA Margin 24.01%
EBIT Margin 17.37%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 3.90%.

Dividend Per Share 0.02
Dividend Yield 3.90%
Dividend Growth (YoY) 20.17%
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -0.66%
Shareholder Yield 3.24%
Earnings Yield 9.39%
FCF Yield n/a
Dividend Details

Stock Splits

The last stock split was on May 4, 2011. It was a forward split with a ratio of 2.

Last Split Date May 4, 2011
Split Type Forward
Split Ratio 2

Scores

FRA:UK2 has an Altman Z-Score of 2.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.73
Piotroski F-Score n/a